Literature DB >> 9446847

Conversion of dietary phylloquinone to tissue menaquinone-4 in rats is not dependent on gut bacteria.

R T Davidson1, A L Foley, J A Engelke, J W Suttie.   

Abstract

The ability of male rats to accumulate menaquinone-4 (MK-4) in tissues when fed a vitamin K-deficient diet supplemented with intraperitoneal phylloquinone (K) as the sole source of vitamin K for 14 d was assessed. In both conventionally housed controls and gnotobiotic rats, supplementation with the equivalent of 1500 microg vitamin K/kg diet increased (P < 0.001) tissue MK-4 concentrations above those of controls fed a vitamin K-deficient diet. MK-4 concentrations were approximately 5 ng/g (11 pmol/g) in liver, 14 ng/g in heart, 17 ng/g in kidney, 50 ng/g in brain and 250 ng/g in mandibular salivary glands of gnotobiotic rats. MK-4 concentrations in conventionally housed rats were higher than in gnotobiotic rats in heart (P < 0.01), brain (P < 0.01) and kidney (P < 0.05) but lower in salivary gland (P < 0.05). Cultures of a kidney-derived cell line (293) converted K to the expoxide of MK-4 in a manner that was dependent on both time of incubation and concentration of vitamin K in the media. A liver-derived cell line (H-35) was less active in carrying out this conversion. These data offer conclusive proof that the tissue-specific formation of MK-4 from K is a metabolic transformation that does not require bacterial transformation to menadione as an intermediate in the process.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9446847     DOI: 10.1093/jn/128.2.220

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  17 in total

1.  Deuterium-labeled phylloquinone has tissue-specific conversion to menaquinone-4 among Fischer 344 male rats.

Authors:  Ala Al Rajabi; Sarah L Booth; James W Peterson; Sang Woon Choi; John W Suttie; M Kyla Shea; Benchun Miao; Michael A Grusak; Xueyan Fu
Journal:  J Nutr       Date:  2012-03-21       Impact factor: 4.798

Review 2.  Recent trends in the metabolism and cell biology of vitamin K with special reference to vitamin K cycling and MK-4 biosynthesis.

Authors:  Martin J Shearer; Paul Newman
Journal:  J Lipid Res       Date:  2014-01-31       Impact factor: 5.922

Review 3.  Menaquinones, bacteria, and the food supply: the relevance of dairy and fermented food products to vitamin K requirements.

Authors:  Barbara Walther; J Philip Karl; Sarah L Booth; Patrick Boyaval
Journal:  Adv Nutr       Date:  2013-07-01       Impact factor: 8.701

Review 4.  Production and application of menaquinone-7 (vitamin K2): a new perspective.

Authors:  Ehsan Mahdinia; Ali Demirci; Aydin Berenjian
Journal:  World J Microbiol Biotechnol       Date:  2016-11-10       Impact factor: 3.312

5.  Identification of UBIAD1 as a novel human menaquinone-4 biosynthetic enzyme.

Authors:  Kimie Nakagawa; Yoshihisa Hirota; Natsumi Sawada; Naohito Yuge; Masato Watanabe; Yuri Uchino; Naoko Okuda; Yuka Shimomura; Yoshitomo Suhara; Toshio Okano
Journal:  Nature       Date:  2010-10-17       Impact factor: 49.962

6.  Effects of the blood coagulation vitamin K as an inhibitor of arterial calcification.

Authors:  Reidar Wallin; Leon Schurgers; Nadeem Wajih
Journal:  Thromb Res       Date:  2008-01-30       Impact factor: 3.944

7.  Vitamin K Analogs Influence the Growth and Virulence Potential of Enterohemorrhagic Escherichia coli.

Authors:  Anne Kijewski; Ingun Lund Witsø; Hildegunn Iversen; Helene Thorsen Rønning; Trine L'Abée-Lund; Yngvild Wasteson; Toril Lindbäck; Marina Aspholm
Journal:  Appl Environ Microbiol       Date:  2020-11-24       Impact factor: 4.792

8.  Vitamin K treatment reduces undercarboxylated osteocalcin but does not alter bone turnover, density, or geometry in healthy postmenopausal North American women.

Authors:  Neil Binkley; Judith Harke; Diane Krueger; Jean Engelke; Nellie Vallarta-Ast; Dessa Gemar; Mary Checovich; Richard Chappell; John Suttie
Journal:  J Bone Miner Res       Date:  2009-06       Impact factor: 6.741

9.  Menadione (vitamin K3) is a catabolic product of oral phylloquinone (vitamin K1) in the intestine and a circulating precursor of tissue menaquinone-4 (vitamin K2) in rats.

Authors:  Yoshihisa Hirota; Naoko Tsugawa; Kimie Nakagawa; Yoshitomo Suhara; Kiyoshi Tanaka; Yuri Uchino; Atsuko Takeuchi; Natsumi Sawada; Maya Kamao; Akimori Wada; Takashi Okitsu; Toshio Okano
Journal:  J Biol Chem       Date:  2013-09-30       Impact factor: 5.157

10.  Tissue Concentrations of Vitamin K and Expression of Key Enzymes of Vitamin K Metabolism Are Influenced by Sex and Diet but Not Housing in C57Bl6 Mice.

Authors:  Stephanie G Harshman; Xueyan Fu; J Philip Karl; Kathryn Barger; Stefania Lamon-Fava; Athan Kuliopulos; Andrew S Greenberg; Donald Smith; Xiaohua Shen; Sarah L Booth
Journal:  J Nutr       Date:  2016-07-06       Impact factor: 4.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.